Highly Extensible Resource for Modeling Event-Driven Supply Chains


  1. Lee BY, Haidari LA, Prosser W, Connor DL, Bechtel R, Dipuve A, Kassim H, Khanlawia B, Brown ST. (2016) Re-designing the Mozambique vaccine supply chain to improve access to vaccines. Vaccine, 34(41): 4998-5004.

  2. Haidari LA, Brown ST, Ferguson M, Bancroft E, Spiker M, Wilcox A, Ambikapathi R, Sampath V, Connor DL, Lee BY. (2016) The economic and operational value of using drones to transport vaccines. Vaccine, 34(34): 4062-7.

  3. Mueller LE, Haidari LA, Wateska AR, Phillips RJ, Schmitz MM, Connor DL, Norman BA, Brown ST, Welling JS, Lee BY. (2016) The impact of implementing a demand forecasting system into a low-income country’s supply chain. Vaccine, 34(32):3663-9.

  4. Lee BY, Connor DL, Wateska AR, Norman BA, Rajgopal J, Cakouros BE, Chen S, Claypool EG, Haidari LA, Karir V, Leonard J, Mueller LE, Paul P, Schmitz MM, Welling JS, Weng Y, Brown ST. (2015) Landscaping the structures of GAVI country vaccine supply chains and testing the effects of radical redesign. Vaccine, 33(36):4451-8.

  5. Norman BA, Rajgopal J, Lim J, Gorham K, Haidari LA, Brown ST, Lee BY. (2015) Modular vaccine packaging increases packing efficiency. Vaccine, 33(27):3135-41.

  6. Lee BY, Schreiber B, Wateska AR, Connor DL, Dicko HM, Jaillard P, Mvundura M, Levin C, Avella M, Haidari LA, Brown ST. (2015) The Benin experience: How computational modeling can assist major vaccine policy changes in low and middle income countries. Vaccine, 33(25):2858-61.

  7. Haidari LA, Wahl B, Brown ST, Privor-Dumm L, Wallman-Stokes C, Gorham K, Connor DL, Wateska AR, Schriber B, Dicko H, Jaillard P, Avella M, Lee BY. (2015) One size does not fit all: The impact of primary vaccine container size on vaccine distribution and delivery. Vaccine, 33(28):3242-7.

  8. Portnoy A, Ozawa S, Grewal S, Norman BA, Rajgopal J, Gorham KM, Haidari LA, Brown ST, Lee BY. (2015) Costs of vaccine programs across 94 low- and middle-income countries. Vaccine, 33(S1):A99-108.

  9. Brown ST, Schreiber B, Cakouros BE, Wateska AR, Dicko HM, Connor DL, Jaillard P, Mvundura M, Norman BA, Levin C, Rajgopal J, Avella M, Lebrun C, Claypool E, Paul P, Lee BY. (2014) The benefits of redesigning Benin's vaccine supply chain. Vaccine, 32(32):4097-103.

  10. Brown ST, Lee BY. (2014) Unless changes are made in Benin, multiple storage and transport bottlenecks may prevent vaccines from reaching the population. Vaccine, 32(21): 2518-9.

  11. Norman BA, Nourollahi S, Chen S, Brown ST, Claypool EG, Connor DL, Schmitz MM, Rajgopal J, Wateska AR, Lee BY. (2013) A passive cold storage device economic model to evaluate selected immunization location scenarios. Vaccine, 31(45):5232-8.

  12. Haidari LA, Connor DL, Wateska AR, Brown ST, Mueller LE, Norman BA, Schmitz MM, Paul P, Rajgopal J, Welling JS, Leonard J, Chen S, Lee BY. (2013) Augmenting transport versus increasing cold storage to improve vaccine supply chains. Plos One, 8(5):e64303.

  13. Assi TM, Brown, ST, Kone S, Norman BA, Djibo A, Connor DL, Wateska AR, Rajgopal J, Slayton RB, Lee BY. (2013) Removing the regional level from the Niger vaccine supply chain. Vaccine, 31(26):2828-34.

  14. Haidari LA, Connor DL, Wateska AR, Brown ST, Mueller LE, Norman BA, Schmitz MM, Paul P, Rajgopal J, Welling JS, Leonard J, Claypool EG, Weng Y, Chen S, Lee BY. (2013) Only adding stationary storage to vaccine supply chains may create and worsen transport bottlenecks. Journal of Public Health Management and Practice, 19(S2):S65-7.

  15. Assi TM, Rookkapan K, Rajgopal J, Sornsrivichai V, Brown ST, Norman BA, Connor DL, Wisniewski SR, Wateska AR, and Lee BY. (2012) How influenza vaccination policy may affect vaccine logistics. Vaccine, 30(30):4517–23.

  16. Lee BY, Cakouros BE, Assi TM, Connor DL, Welling J, Kone S, Djibo A, Wateska AR, Pierre L, Brown ST. (2012) The impact of making vaccines thermostable in Niger’s vaccine supply chain. Vaccine, 30(38):5637-43.

  17. Lee BY, Assi T, Rajgopal J, Norman BA, Chen S, Brown ST, Bailey RR, Kone S, Kenea H, Welling J, Connor DL, Wateska AR, Jana A, Wiringa AE, Van Panhuis WG, Burke DS. (2012) Impact of introducing the pneumococcal and rotavirus vaccines into the routine immunization program in Niger. Am J Public Health, 102(2):269-76.

  18. Lee BY, Assi T, Rookkapan K, Connor DL, Rajgopal J, Sornsrivichai V, Brown ST, Welling J, Norman BA, Chen S, Bailey RR, Wiringa AE, Wateska AR, Jana A, Van Panhuis WG, Burke DS. (2011) Replacing the measles ten-dose vaccine presentation with the single-dose presentation in Thailand. Vaccine, 29(21):3811-7.

  19. Lee BY, Assi T, Rookkapan K, Wateska AR, Rajgopal J, Sornsrivichai V, Chen S, Brown ST, Welling J, Norman BA, Connor DL, Bailey RR, Jana A, Van Panhuis WG, Burke DS. (2011) Maintaining vaccine delivery following the introduction of the rotavirus and pneumococcal vaccines in Thailand. Plos One, 6(9):e24673.

  20. Assi T, Brown ST, Djibo A, Norman BA, Rajgopal J, Welling J, Chen S, Bailey RR, Kone S, Kenea H, Connor DL, Wateska AR, Jana A, Wisniewski SR, Van Panhuis WG, Burke DS, Lee BY. (2011) Impact of changing the measles vaccine vial size on Niger’s vaccine supply chain: a computational model. BMC Public Health, 11:425.

  21. Rajgopal J, Connor DL, Assi T, Norman BA, Chen S, Bailey RR, Long AR, Wateska AR, Bacon KM, Brown ST, Burke DS, Lee BY. (2011) The optimal number of routine vaccines to order at health clinics in low or middle income countries. Vaccine, 29(33):5512-8.

  22. Lee BY, Norman BA, Assi T, Chen S, Bailey RR, Rajgopal J, Brown ST, Wiringa AE, Burke DS. (2010) Single versus multi-dose vaccine vials: an economic computational model. Vaccine, 28(32):5292-300.

  23. Lee BY and Burke DS. (2010) Constructing target product profiles (TPPs) to help vaccines overcome post-approval obstacles. Vaccine, 28(16):2806-9.